An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis
Clinical trial NCT03943147 · TERMINATED
Trial details
- NCT number
- NCT03943147
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2020-10-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.